A proteomic view at T cell costimulation

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Lichtenfels, Rudolf ^a   Rappl, Gunter ^b   Hombach, Andreas A ^b   Recktenwald, Christian V ^a   Dressler, Sven P ^a   Abken, Hinrich ^b   Seliger, Barbara ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC PROTEIN; CALMODULIN; CD28 ANTIGEN; CD3 ANTIGEN; CD69 ANTIGEN; GLYCERALDEHYDE 3 PHOSPHATE; GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR; GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR 2; INTERLEUKIN 2; LACTATE DEHYDROGENASE; OKT 3; PROTEOME; T LYMPHOCYTE RECEPTOR; THROMBOCYTE BASIC PROTEIN; UNCLASSIFIED DRUG; ANTIBODY; LECTIN; LEUKOCYTE ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; T LYMPHOCYTE ANTIGEN;

ARTICLE; CELLULAR IMMUNITY; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOSKELETON; HUMAN; HUMAN CELL; METABOLIC REGULATION; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEOMICS; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; CYTOLOGY; FLOW CYTOMETRY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; T LYMPHOCYTE; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANTIBODIES; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD3; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CYTOSKELETON; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-2; LECTINS, C-TYPE; LYMPHOCYTE ACTIVATION; MUROMONAB-CD3; PROTEOME; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 84860015324     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032994     Document Type: Article

References (58)

1. Bour-Jordan H, Bluestone JA, (2009) Regulating the regulators: costimulatory signals control the homeostasis and function of regulatory T cells. Immunol Rev 229: 41-66.
2. Lafferty KJ, Prowse SJ, Simeonovic CJ, Warren HS, (1983) Immunobiology of tissue transplantation: a return to the passenger leukocyte concept. Annu Rev Immunol 1: 143-173.
3. Sharpe AH, (2009) Mechanisms of costimulation. Immunol Rev 229: 5-11.
4. Duttagupta PA, Boesteanu AC, Katsikis PD, (2009) Costimulation signals for memory CD8+ T cells during viral infections. Crit Rev Immunol 29: 469-486.
5. Paterson AM, Vanguri VK, Sharpe AH, (2009) SnapShot: B7/CD28 costimulation. Cell 137: 974-974 e971.
6. Poirier N, Blancho G, Vanhove B, (2011) A more selective costimulatory blockade of the CD28-B7 pathway. Transpl Int 24: 2-11.
7. Jenkins MK, Chen CA, Jung G, Mueller DL, Schwartz RH, (1990) Inhibition of antigen-specific proliferation of type 1 murine T cell clones after stimulation with immobilized anti-CD3 monoclonal antibody. J Immunol 144: 16-22.
8. Schwartz RH, Mueller DL, Jenkins MK, Quill H, (1989) T-cell clonal anergy. Cold Spring Harb Symp Quant Biol 54 Pt 2: 605-610.
9. Fuse S, Tsai CY, Rommereim LM, Zhang W, Usherwood EJ, (2011) Differential requirements for CD80/86-CD28 costimulation in primary and memory CD4 T cell responses to vaccinia virus. Cell Immunol 266: 130-134.
10. Borowski AB, Boesteanu AC, Mueller YM, Carafides C, Topham DJ, et al. (2007) Memory CD8+ T cells require CD28 costimulation. Journal of immunology 179: 6494-6503.
11. Boesteanu AC, Katsikis PD, (2009) Memory T cells need CD28 costimulation to remember. Seminars in immunology 21: 69-77.
12. Fuse S, Zhang W, Usherwood EJ, (2008) Control of memory CD8+ T cell differentiation by CD80/CD86-CD28 costimulation and restoration by IL-2 during the recall response. Journal of immunology 180: 1148-1157.
13. Garcon F, Patton DT, Emery JL, Hirsch E, Rottapel R, et al. (2008) CD28 provides T-cell costimulation and enhances PI3K activity at the immune synapse independently of its capacity to interact with the p85/p110 heterodimer. Blood 111: 1464-1471.
14. Bhatia S, Sun K, Almo SC, Nathenson SG, Hodes RJ, (2010) Dynamic equilibrium of B7-1 dimers and monomers differentially affects immunological synapse formation and T cell activation in response to TCR/CD28 stimulation. J Immunol 184: 1821-1828.
15. Yokosuka T, Saito T, (2009) Dynamic regulation of T-cell costimulation through TCR-CD28 microclusters. Immunol Rev 229: 27-40.
16. Shen K, Thomas VK, Dustin ML, Kam LC, (2008) Micropatterning of costimulatory ligands enhances CD4+ T cell function. Proc Natl Acad Sci U S A 105: 7791-7796.
17. Hombach AA, Kofler D, Hombach A, Rappl G, Abken H, (2007) Effective proliferation of human regulatory T cells requires a strong costimulatory CD28 signal that cannot be substituted by IL-2. J Immunol 179: 7924-7931.
18. Jindra PT, Bagley J, Godwin JG, Iacomini J, (2010) Costimulation-dependent expression of microRNA-214 increases the ability of T cells to proliferate by targeting Pten. J Immunol 185: 990-997.
19. Boise LH, Minn AJ, Noel PJ, June CH, Accavitti MA, et al. (2010) CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-xL. Immunity. 1995. 3: 87-98. J Immunol 185: 3788-3799.
20. Thiel M, Wolfs MJ, Bauer S, Wenning AS, Burckhart T, et al. (2010) Efficiency of T-cell costimulation by CD80 and CD86 cross-linking correlates with calcium entry. Immunology 129: 28-40.
21. Waibler Z, Sender LY, Merten C, Hartig R, Kliche S, et al. (2008) Signaling signatures and functional properties of anti-human CD28 superagonistic antibodies. PLoS ONE 3: e1708.
22. Ford ML, Larsen CP, (2009) Translating costimulation blockade to the clinic: lessons learned from three pathways. Immunol Rev 229: 294-306.
23. Linsley PS, Nadler SG, (2009) The clinical utility of inhibiting CD28-mediated costimulation. Immunol Rev 229: 307-321.
24. Verbinnen B, Billiau AD, Vermeiren J, Galicia G, Bullens DM, et al. (2008) Contribution of regulatory T cells and effector T cell deletion in tolerance induction by costimulation blockade. J Immunol 181: 1034-1042.
25. Vinh A, Chen W, Blinder Y, Weiss D, Taylor WR, et al. (2010) Inhibition and genetic ablation of the B7/CD28 T-cell costimulation axis prevents experimental hypertension. Circulation 122: 2529-2537.
26. Yang J, Riella LV, Boenisch O, Popoola J, Robles S, et al. (2009) Paradoxical functions of B7: CD28 costimulation in a MHC class II-mismatched cardiac transplant model. Am J Transplant 9: 2837-2844.
27. Rosenblatt J, Wu Z, Vasir B, Zarwan C, Stone R, et al. (2010) Generation of tumor-specific T lymphocytes using dendritic cell/tumor fusions and anti-CD3/CD28. J Immunother 33: 155-166.
28. Chmielewski M, Hombach AA, Abken H, (2011) CD28 cosignalling does not affect the activation threshold in a chimeric antigen receptor-redirected T-cell attack. Gene Ther 18: 62-72.
29. Brockmeyer C, Paster W, Pepper D, Tan CP, Trudgian DC, et al. (2011) T cell receptor (TCR)-induced tyrosine phosphorylation dynamics identifies THEMIS as a new TCR signalosome component. J Biol Chem 286: 7535-7547.
30. Iwai LK, Benoist C, Mathis D, White FM, (2010) Quantitative phosphoproteomic analysis of T cell receptor signaling in diabetes prone and resistant mice. J Proteome Res 9: 3135-3145.
31. Lange S, Sylvester M, Schumann M, Freund C, Krause E, (2010) Identification of phosphorylation-dependent interaction partners of the adapter protein ADAP using quantitative mass spectrometry: SILAC vs (18)O-labeling. J Proteome Res 9: 4113-4122.
32. Mayya V, Lundgren DH, Hwang SI, Rezaul K, Wu L, et al. (2009) Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions. Sci Signal 2: ra46.
33. Nguyen VH, Shashidhar S, Chang DS, Ho L, Kambham N, et al. (2008) The impact of regulatory T cells on T-cell immunity following hematopoietic cell transplantation. Blood 111: 945-953.
34. Heller M, Goodlett DR, Watts JD, Aebersold R, (2000) A comprehensive characterization of the T-cell antigen receptor complex composition by microcapillary liquid chromatography-tandem mass spectrometry. Electrophoresis 21: 2180-2195.
35. Kobayashi M, Katagiri T, Kosako H, Iida N, Hattori S, (2007) Global analysis of dynamic changes in lipid raft proteins during T-cell activation. Electrophoresis 28: 2035-2043.
36. Kronfeld K, Hochleitner E, Mendler S, Goldschmidt J, Lichtenfels R, et al. (2005) B7/CD28 costimulation of T cells induces a distinct proteome pattern. Mol Cell Proteomics 4: 1876-1887.
37. Sheng WY, Wang TC, (2009) Proteomic analysis of the differential protein expression reveals nuclear GAPDH in activated T lymphocytes. PLoS ONE 4: e6322.
38. de Wet B, Zech T, Salek M, Acuto O, Harder T, (2011) Proteomic characterization of plasma membrane-proximal T cell activation responses. The Journal of biological chemistry 286: 4072-4080.
39. Fathman CG, Lineberry NB, (2007) Molecular mechanisms of CD4+ T-cell anergy. Nature reviews Immunology 7: 599-609.
40. Bini L, Pacini S, Liberatori S, Valensin S, Pellegrini M, et al. (2003) Extensive temporally regulated reorganization of the lipid raft proteome following T-cell antigen receptor triggering. The Biochemical journal 369: 301-309.
41. Iida N, Haisa M, Igarashi A, Pencev D, Grotendorst GR, (1996) Leukocyte-derived growth factor links the PDGF and CXC chemokine families of peptides. FASEB J 10: 1336-1345.
42. von Hundelshausen P, Petersen F, Brandt E, (2007) Platelet-derived chemokines in vascular biology. Thromb Haemost 97: 704-713.
43. Nguyen V, Cao L, Lin JT, Hung N, Ritz A, et al. (2009) A new approach for quantitative phosphoproteomic dissection of signaling pathways applied to T cell receptor activation. Molecular & Cellular Proteomics: MCP 8: 2418-2431.
44. Lin SL, Chien CW, Han CL, Chen ES, Kao SH, et al. (2010) Temporal proteomics profiling of lipid rafts in CCR6-activated T cells reveals the integration of actin cytoskeleton dynamics. Journal of proteome research 9: 283-297.
45. Tristan C, Shahani N, Sedlak TW, Sawa A, (2011) The diverse functions of GAPDH: views from different subcellular compartments. Cell Signal 23: 317-323.
46. Patterson RL, van Rossum DB, Kaplin AI, Barrow RK, Snyder SH, (2005) Inositol 1,4,5-trisphosphate receptor/GAPDH complex augments Ca2+ release via locally derived NADH. Proc Natl Acad Sci U S A 102: 1357-1359.
47. Kumagai H, Sakai H, (1983) A porcine brain protein (35 K protein) which bundles microtubules and its identification as glyceraldehyde 3-phosphate dehydrogenase. J Biochem 93: 1259-1269.
48. Reiss N, Oplatka A, Hermon J, Naor Z, (1996) Phosphatidylserine directs differential phosphorylation of actin and glyceraldehyde-3-phosphate dehydrogenase by protein kinase C: possible implications for regulation of actin polymerization. Biochem Mol Biol Int 40: 1191-1200.
49. Durrieu C, Bernier-Valentin F, Rousset B, (1987) Microtubules bind glyceraldehyde 3-phosphate dehydrogenase and modulate its enzyme activity and quaternary structure. Arch Biochem Biophys 252: 32-40.
50. Tisdale EJ, Azizi F, Artalejo CR, (2009) Rab2 utilizes glyceraldehyde-3-phosphate dehydrogenase and protein kinase C{iota} to associate with microtubules and to recruit dynein. J Biol Chem 284: 5876-5884.
51. Hara MR, Agrawal N, Kim SF, Cascio MB, Fujimuro M, et al. (2005) S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding. Nat Cell Biol 7: 665-674.
52. Park J, Han D, Kim K, Kang Y, Kim Y, (2009) O-GlcNAcylation disrupts glyceraldehyde-3-phosphate dehydrogenase homo-tetramer formation and mediates its nuclear translocation. Biochim Biophys Acta 1794: 254-262.
53. Carujo S, Estanyol JM, Ejarque A, Agell N, Bachs O, et al. (2006) Glyceraldehyde 3-phosphate dehydrogenase is a SET-binding protein and regulates cyclin B-cdk1 activity. Oncogene 25: 4033-4042.
54. Nyman TA, Rosengren A, Syyrakki S, Pellinen TP, Rautajoki K, et al. (2001) A proteome database of human primary T helper cells. Electrophoresis 22: 4375-4382.
55. Michalek RD, Nelson KJ, Holbrook BC, Yi JS, Stridiron D, et al. (2007) The requirement of reversible cysteine sulfenic acid formation for T cell activation and function. Journal of immunology 179: 6456-6467.
56. Seliger B, Lichtenfels R, Atkins D, Bukur J, Halder T, et al. (2005) Identification of fatty acid binding proteins as markers associated with the initiation and/or progression of renal cell carcinoma. Proteomics 5: 2631-2640.
57. Croci S, Recktenwald CV, Lichtenfels R, Nicoletti G, Dressler SP, et al. (2010) Proteomic and PROTEOMEX profiling of mammary cancer progression in a HER-2/neu oncogene-driven animal model system. Proteomics 10: 3835-3853.
58. Lichtenfels R, Dressler SP, Zobawa M, Recktenwald CV, Ackermann A, et al. (2009) Systematic comparative protein expression profiling of clear cell renal cell carcinoma: a pilot study based on the separation of tissue specimens by two-dimensional gel electrophoresis. Mol Cell Proteomics 8: 2827-2842.